Drug Discovery · San Mateo, CA · Founded 2014 · Privately Held (backing)
Operator of a small molecule drug discovery firm intended to introduce new treatments for cancer patients. Vivace Therapeutics is based in San Mateo, CA and was founded in 2014. It was valued at $125 million at its later-stage round in Feb 2025, the last priced event on record. It has raised $105 million across 4 recorded rounds; the latest was a $35 million Series D in Feb 2025.
PMV mark · valuation
$125.0M
Oct 2026
Priced at
its later-stage round
Feb 2025
Total raised
$105.0M
Last round
Later Stage VC (Series D)
Feb 2025
Team — not yet on record
No current team members for Vivace Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vivace Therapeutics with a free account
·The complete investor list: 11 names
·Watch Vivace Therapeutics: the Monday email on marks, rounds and moves
